Gherman, A., Căinap, C., Constantin, A.-M., Cetean, S. and Căinap, S. (2017) “Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab”, Medicine and Pharmacy Reports, 90(4), pp. 377-384. doi: 10.15386/cjmed-745.